Ovarian cancer is a silent killer, often diagnosed at an advanced stage when treatment options are limited. However, it doesn’t have to be this way.
In this comprehensive guide, we delve into the intricacies of ovarian cancer, exploring its risk factors, symptoms, screening methods, and strategies for prevention and early detection.
Ovarian cancer occurs when abnormal cells in the ovary begin to grow out of control and form a tumour. The ovaries, which are part of the female reproductive system, produce eggs and hormones such as oestrogen and progesterone.
Ovarian cancer can develop in different parts of the ovary, including the epithelial cells lining the surface, the germ cells that produce eggs, and the stromal cells that produce hormones.
Several factors may increase a woman’s risk of developing ovarian cancer:
Ovarian cancer may not cause noticeable symptoms in the early stages, or symptoms may be vague and easily attributed to other conditions. However, as the cancer progresses, the following symptoms may develop:
It’s essential to note that these symptoms can be caused by conditions other than ovarian cancer. However, if they persist for more than a few weeks or worsen over time, it’s crucial to consult a healthcare professional for further evaluation.
Early detection plays a critical role in improving outcomes for ovarian cancer by enabling timely diagnosis and intervention. Ovarian cancer often presents with vague or subtle symptoms in its early stages, making it challenging to detect. However, when diagnosed early, the cancer is more likely to be confined to the ovaries, making treatment more effective and increasing the chances of successful outcomes.
Early detection allows for less aggressive treatment options, such as surgery and chemotherapy, which can preserve fertility and improve quality of life. Additionally, early diagnosis provides opportunities for patients to participate in clinical trials and access innovative treatments that may further enhance their prognosis.
Although early detection is key to improving outcomes for ovarian cancer patients, unfortunately unlike breast or cervical cancer, there are currently no reliable screening tests that can determine the average risk of the disease in women.
The most commonly used screening test, known as the CA-125 blood test, measures the levels of a protein called CA-125 in the blood. Elevated CA-125 levels may indicate the presence of ovarian cancer, but this test is not specific to ovarian cancer and can be elevated in other conditions, leading to false-positive results.
Transvaginal ultrasound (TVUS) is another imaging test that may be used to detect ovarian abnormalities. During a TVUS, a wand-shaped device is inserted into the vagina to produce images of the ovaries. While TVUS can help identify ovarian masses, it is not recommended for routine screening due to its limited ability to detect early-stage disease.
Despite the lack of effective screening tests for the general population, women at high risk of ovarian cancer, such as those with a family history of the disease or known genetic mutations, may benefit from regular monitoring and screening, including CA-125 testing and TVUS.
The stage of ovarian cancer is determined by where the cancer started and how much it has spread throughout the body.
Cancer in the ovaries can be confined to just one or both ovaries, with the tumour either on the surface or inside.
The cancer has spread to other pelvic organs, including the uterus and fallopian tubes. It has also spread to other pelvic organs like the bladder.
The cancer has spread from the pelvis to the abdomen lining or nearby lymph nodes. It could also have spread to other areas like the peritoneum or lymph nodes in the abdomen or behind the peritoneum, with varying sizes and spread.
The cancer has spread to distant organs, as well as to the fluid around the lungs. It has also spread to other organs like the liver or spleen.
Treatment options for ovarian cancer depend on factors such as the stage of the cancer, the patient’s overall health, and personal preferences. Common treatment modalities include:
Surgery is a common treatment for ovarian cancer, especially in the early stages. It involves removing as much of the tumour as possible to reduce symptoms and possibly eliminate the cancer cells. Surgery may be followed by other treatments like chemotherapy or radiation. Patients should talk to their healthcare team about the risks and benefits of surgery.
Chemotherapy is a common treatment for ovarian cancer patients post-surgery to destroy remaining cancer cells and reduce recurrence risk. It uses powerful drugs to target rapidly dividing cancer cells in the body. Administration methods include IV, oral, or intraperitoneal chemotherapy. Treatment varies based on cancer stage, subtype, and patient health. Despite side effects such as nausea and fatigue, advancements in supportive care help improve patient quality of life. Regular monitoring by healthcare providers is crucial for managing side effects and achieving optimal outcomes.
Targeted therapy is a key treatment option for ovarian cancer patients, especially those with advanced disease. These drugs target specific molecular pathways in cancer cells, minimising harm to healthy tissues. Common targeted therapy drugs for ovarian cancer include PARP inhibitors and angiogenesis inhibitors. Patients should undergo molecular testing to determine eligibility for treatment and personalise their care with their healthcare team.
Immunotherapy is a promising treatment for ovarian cancer, especially in advanced cases. It harnesses the immune system to attack cancer cells. Drugs like immune checkpoint inhibitors help the immune system recognise and destroy cancer cells. Effectiveness varies based on factors such as tumour environment and biomarkers. Ongoing research aims to improve outcomes and expand the availability of immunotherapy for ovarian cancer patients.
Hormone therapy is a treatment option for some ovarian cancer patients with hormone-sensitive tumours. It blocks hormone effects to slow or shrink tumour growth. It is not a first-line treatment but can be used for recurrent or metastatic disease with hormone receptor-positive tumours. Aromatase inhibitors and SERMs are common hormone therapy drugs. It can be taken orally or by injection, often in combination with other treatments. Close monitoring by healthcare providers is crucial to assess response and manage side effects.
Radiation therapy is not always the first choice for treating ovarian cancer but may be used to relieve symptoms or target specific areas affected by the disease. It uses high-energy beams to destroy cancer cells or shrink tumours and can help with pain caused by metastatic tumours in the abdomen or pelvis. It can be a part of palliative care plans for advanced or recurrent cases and may be delivered externally or internally depending on the tumour location. Communication between patients, oncologists, and radiation therapists is important to personalise treatment and reduce side effects.
Clinical trials are important for advancing ovarian cancer treatment options by evaluating new drugs and therapeutic approaches. Participation in trials gives patients access to innovative treatments and allows them to contribute to the development of new therapies. Patients undergo a thorough evaluation before enrolling to understand the risks and benefits. Collaboration between patients, oncologists, and research teams is key for safe and effective participation in clinical trials.
While it’s not possible to prevent ovarian cancer entirely, several strategies may help reduce the risk:
Living with ovarian cancer can be challenging, but it’s important to remember that you are not alone. From managing symptoms like fatigue and pain to coping with emotional stress, there are numerous resources available to support you through this journey.
Receiving a cancer diagnosis may be daunting. It is important to remember that knowledge is power. It is most important to understand the risk factors, symptoms, and screening methods for ovarian cancer to ensure you get a better understanding of the future.
Ensure to ask your medical team any questions that you may have in your mind. Proper communication will make the journey easier for you.
Early warning signs of ovarian cancer include persistent abdominal or pelvic pain, bloating, difficulty eating, feeling full quickly, and changes in bowel or urinary habits.
Preventing ovarian cancer involves maintaining a healthy lifestyle, including regular exercise, a balanced diet rich in fruits and vegetables, and avoiding tobacco use.
Individuals with a family history of ovarian cancer, BRCA gene mutations, or Lynch syndrome are at higher risk for ovarian cancer.
Dr Raja Arif Shah Raja Ismail
Consultant Obstetrician & Gynae-Oncologist
Sources:
Spread the love, follow us on our social media channels